T1	Premise 44 279	A 75-year-old woman, with menopause at age 52, with no family or personal history of fracture, diagnosed with temporal arteritis, who is going to start treatment with high-dose prednisone and expects to be treated for at least one year
T3	Premise 342 393	Preventive treatment for osteoporosis is considered
T4	Claim 455 490	Request DXA and wait for the result
T5	Claim 495 597	Assess absolute risk of fracture using the FRAX questionnaire without BMD and treat only if it is high
T6	Claim 602 665	Start treatment with bisphosphonates and vitamin D (800 IU/day)
T7	Claim 670 736	Administer calcium supplementation (1g) and vitamin D (800 IU/day)
T8	Claim 741 798	Assess for osteopenia on radiographs and treat if present
T9	Claim 1245 1320	Therefore, and for this reason alone, options 1, 2 and 5 would be discarded
T10	Premise 1322 1372	the three of them have another conditioning factor
R1	Support Ent1:T10 Ent2:T9	
T11	Marker 1245 1254	Therefore
T12	Marker 924 929	Since
T13	Claim 930 994	a prolonged and high-dose prednisone regimen will be established
T14	Claim 996 1243	it is advisable, in addition to the non-pharmacological preventive measures, to initiate treatment in any case to minimize the secondary loss of bone mass that occurs with the administration of glucocorticoids (and, above all, in the first months)
R2	Support Ent1:T13 Ent2:T14	
T15	Claim 842 922	there are no clinical risk factors for osteoporosis prior to the current disease
R3	Attack Ent1:T15 Ent2:T4	
T2	Diagnostics 463 466	DXA
R4	Support Ent1:T14 Ent2:T9	
R5	Attack Ent1:T9 Ent2:T4	
R6	Attack Ent1:T9 Ent2:T5	
R7	Attack Ent1:T9 Ent2:T8	
T16	Treatment 623 638	bisphosphonates
T17	Treatment 643 665	vitamin D (800 IU/day)
T18	Premise 1411 1440	a person over 65 years of age
T19	Claim 1442 1641	an appropriate attitude would be to administer calcium supplements (corticosteroids are osteopenizantes because they produce, among other mechanisms, a negative balance of this element) and vitamin D
T20	Disease 881 893	osteoporosis
T21	Treatment 1489 1508	calcium supplements
T22	Treatment 1632 1641	vitamin D
R8	Support Ent1:T18 Ent2:T19	
R9	Support Ent1:T19 Ent2:T7	
T23	Treatment 681 709	calcium supplementation (1g)
T24	Treatment 714 736	vitamin D (800 IU/day)
T25	Claim 1643 1710	The option of associating a bisphosphonate could also be considered
T26	Marker 1712 1715	but
T27	Claim 1716 1764	calcium supplementation is missing in proposal 3
R10	Attack Ent1:T27 Ent2:T25	
R11	Support Ent1:T25 Ent2:T6	
R12	Attack Ent1:T27 Ent2:T6	
T28	Treatment 1671 1685	bisphosphonate
T29	Treatment 1716 1739	calcium supplementation
